Colorectal Neoplasms Clinical Trials in Berlin
5 recruitingBerlin, Germany
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer400 enrolled383 locationsNCT05253651
Recruiting
Phase 3
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Janssen Research & Development, LLC1,000 enrolled231 locationsNCT06662786
Recruiting
Phase 3
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Janssen Research & Development, LLC700 enrolled229 locationsNCT06750094
Recruiting
Establishment of a Tumor Bank for Tissue Samples
Breast NeoplasmsOvarian NeoplasmsLung Neoplasms+3 more
Medical University of Vienna10,000 enrolled3 locationsNCT01789229
Recruiting
Establishment of a Tumor Bank for Blood Samples
Breast NeoplasmsOvarian NeoplasmsLung Neoplasms+3 more
Medical University of Vienna10,000 enrolled6 locationsNCT01763125